How the ATR protein helps make healthy sperm and eggs

Coordination of Atr Signaling for Genetic Quality Control, Silencing, and DNA Repair during Meiosis

['FUNDING_R01'] · CORNELL UNIVERSITY · NIH-11377599

This work looks at how the ATR protein fixes DNA and silences problematic chromosomes during sperm and egg formation to help prevent miscarriages and birth defects for people trying to have children.

Quick facts

Phase['FUNDING_R01']
Study typeNih_funding
SexAll
SponsorCORNELL UNIVERSITY (nih funded)
Locations1 site (ITHACA, UNITED STATES)
Trial IDNIH-11377599 on ClinicalTrials.gov

What this research studies

From a patient's perspective, researchers are examining how the ATR protein coordinates DNA repair, chromosome pairing, and the silencing of unpaired sex-chromosome regions during the special cell division that makes eggs and sperm. They will use laboratory models, genetics, genome-wide assays such as ATAC-seq, and imaging to follow these processes at the molecular level. The project focuses on events that, when they go wrong, lead to chromosome errors (aneuploidy) that cause miscarriages, infertility, or conditions like Klinefelter syndrome. By revealing the detailed steps that maintain genetic quality in gametes, the team hopes to identify targets that could one day reduce reproductive loss and birth defects.

Who could benefit from this research

Good fit: People affected by recurrent miscarriage, unexplained infertility with suspected chromosomal causes, or families concerned about sex-chromosome disorders could eventually benefit from this line of work.

Not a fit: Because this is laboratory-based basic research, it is unlikely to offer direct or immediate treatment benefits to patients right now.

Why it matters

Potential benefit: If successful, this research could point to ways to reduce miscarriages and birth defects by preventing chromosome errors during egg and sperm formation.

How similar studies have performed: Prior basic studies, mainly in animal models, have shown ATR plays key roles in DNA repair and meiotic chromosome silencing, but translating those findings into human treatments is still early and largely untested.

Where this research is happening

ITHACA, UNITED STATES

Researchers

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page below.

View on NIH RePORTER →

Conditions: Breast Cancer Carboxy-Terminal Domain

Last reviewed 2026-05-15 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.